Literature DB >> 12067301

CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7).

P Utaisincharoen1, N Anuntagool, P Chaisuriya, S Pichyangkul, S Sirisinha.   

Abstract

Synthetic CpG containing oligodeoxynucleotide (CpG ODN) is recognized for its ability to activate cells to produce several cytokines, such as IL-12 and TNF-alpha. In the present study we have demonstrated that CpG ODN 1826, known for its immunostimulatory activity in the mouse system could, by itself, induce nitric oxide (NO) and inducible nitric oxide synthase (iNOS) production from mouse macrophage cell line (RAW 264.7). Neutralizing antibody against TNF-alpha was not able to inhibit NO or iNOS production from the CpG ODN 1826-activated macrophages, suggesting that although the TNF-alpha was also produced by CpG ODN-activated macrophages, the production of iNOS was not mediated through TNF-alpha. Although both CpG ODN 1826 and lipopolysaccharide (LPS) were able to stimulate NO and iNOS production, the exposure time required for maximum production of NO and iNOS for the CpG ODN 1826-activated macrophages was significantly longer than those activated with LPS. These results were due probably to a delay of NF-kappaB translocation, as indicated by the delay of IkappaBalpha degradation. Moreover, the fact that chloroquine abolished NO and iNOS production from the cells treated with CpG ODN 1826 but not from those treated with LPS suggested that the induction of NO and iNOS production from the cells stimulated with CpG ODN (1826) also required endosomal maturation/acidification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12067301      PMCID: PMC1906257          DOI: 10.1046/j.1365-2249.2002.01866.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Short time exposure to lipopolysaccharide is sufficient to activate human monocytes.

Authors:  P Gallay; C V Jongeneel; C Barras; M Burnier; J D Baumgartner; M P Glauser; D Heumann
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

Review 2.  Nitric oxide and macrophage function.

Authors:  J MacMicking; Q W Xie; C Nathan
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.

Authors:  R Medzhitov; P Preston-Hurlburt; C A Janeway
Journal:  Nature       Date:  1997-07-24       Impact factor: 49.962

5.  Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock.

Authors:  T Sparwasser; T Miethke; G Lipford; A Erdmann; H Häcker; K Heeg; H Wagner
Journal:  Eur J Immunol       Date:  1997-07       Impact factor: 5.532

6.  A family of human receptors structurally related to Drosophila Toll.

Authors:  F L Rock; G Hardiman; J C Timans; R A Kastelein; J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

7.  Macrophages ingest and are activated by bacterial DNA.

Authors:  K J Stacey; M J Sweet; D A Hume
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

Review 8.  Nitric oxide as a secretory product of mammalian cells.

Authors:  C Nathan
Journal:  FASEB J       Date:  1992-09       Impact factor: 5.191

9.  Endotoxin induces rapid protein tyrosine phosphorylation in 70Z/3 cells expressing CD14.

Authors:  J Han; J D Lee; P S Tobias; R J Ulevitch
Journal:  J Biol Chem       Date:  1993-11-25       Impact factor: 5.157

10.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

Authors:  J P Messina; G S Gilkeson; D S Pisetsky
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

View more
  16 in total

1.  DNA-based fluorescent probes of NOS2 activity in live brains.

Authors:  Aneesh T Veetil; Junyi Zou; Katharine W Henderson; Maulik S Jani; Shabana M Shaik; Sangram S Sisodia; Melina E Hale; Yamuna Krishnan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-17       Impact factor: 11.205

2.  CpG oligodeoxynucleotide 2006 and miltefosine, a potential combination for treatment of experimental visceral leishmaniasis.

Authors:  Suman Gupta; Shraddha A Sane; Nishi Shakya; Preeti Vishwakarma; W Haq
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

3.  Induction of inducible nitric oxide synthase (iNOS) in Porphyromonas gingivalis LPS-treated mouse macrophage cell line (RAW264.7) requires Toll-like receptor 9.

Authors:  Matsayapan Pudla; Ratchapin Srisatjaluk; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2018-07-06       Impact factor: 4.575

4.  Intratumoral delivery of brachytherapy and immunotherapy by a thermally triggered polypeptide depot.

Authors:  Garrett Kelly; Joshua J Milligan; Eric M Mastria; Sarah Kim; Stephanie R Zelenetz; Jarrett Dobbins; Leon Y Cai; Xinghai Li; Smita K Nair; Ashutosh Chilkoti
Journal:  J Control Release       Date:  2022-01-22       Impact factor: 9.776

5.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

6.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei.

Authors:  David M Waag; Michael J McCluskie; Ningli Zhang; Arthur M Krieg
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

8.  Regulation of sterile α- and armadillo motif (SARM) containing protein expression in Pam2CSK4- and Pam3CSK4-activated mouse macrophage cell line (RAW264.7) requires TLR9.

Authors:  Matsayapan Pudla; Panthong Kulsantiwong; Chanya Srisaowakarn; Pongsak Utaisincharoen
Journal:  Inflamm Res       Date:  2017-09-09       Impact factor: 4.575

9.  CpG ODN enhances uptake of bacteria by mouse macrophages.

Authors:  P Utaisincharoen; W Kespichayawattana; N Anuntagool; P Chaisuriya; S Pichyangkul; A M Krieg; S Sirisinha
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

10.  Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis.

Authors:  Barbara M Judy; Katherine Taylor; Arpaporn Deeraksa; R Katie Johnston; Janice J Endsley; Sudhamathi Vijayakumar; Judith F Aronson; D Mark Estes; Alfredo G Torres
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.